Risks of PPIs: What’s Real, What Needs More Research

New studies have linked reflux medications to dementia and other diseases. Should you worry? A Michigan Medicine expert explains the science.

7:00 AM

Author | Rene Wisely

For more than 30 years, medications such as omeprazole (Prilosec), lansoprazole (Prevacid) and esomeprazole (Nexium) have been the go-to treatment for acid-related disorders of the digestive tract including gastroesophageal reflux disease (GERD) and peptic ulcer disease.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Called proton pump inhibitors (PPIs), an estimated 15 million Americans use them — both prescription and over-the-counter varieties.

While acid contributes to the breakdown and digestion of food, sometimes it eats away at the protective mucous barrier that lines the digestive organs, causing ulcers, and can lead to heartburn or regurgitation.

A PPI taken 30-60 minutes before a meal dramatically reduces the acid production of certain cells in the stomach, giving a chance for ulcers to heal and reduce reflux.

"PPIs really improve the quality of life of some patients," says Michigan Medicine's Jacob Kurlander, M.D., a clinical lecturer and gastroenterologist.

Questioning recent research

In the past couple of years, some studies have raised concern about possible adverse effects of long-term PPI use. It's a frightening list, including low magnesium, low vitamin D, stroke, Clostridium difficile (C. diff) infection, bone fractures, heart attacks, stomach cancer, pancreatic cancer, kidney disease and dementia.

SEE ALSO: Is It Safe to Take PPIs? A Gastroenterologist Explains the Risks

"Patients are coming to me with questions," Kurlander says. But worry about these drugs' risks shouldn't be automatic.

When such research is published, the medical community should pause and examine each study individually on its own merits, Kurlander says.

"What's interesting is there are often studies that go both ways, that PPIs may be either protective or harmful," he says. "The key is to look at the quality of the study." This has been the case with dementia, heart attacks and pneumonia.

A common shortcoming of studies showing adverse effects from PPIs is that they are often observational studies. Unlike randomized controlled trials, observational studies can have distorted conclusions because of difficulty accounting for certain unmeasured variables.

A person who is obese, for example, is at an increased risk for reflux because their gut pushes on their stomach, causing the acid to create heartburn. An obese person also is more likely to have cardiovascular disease, so that increases their risk for heart attacks. "Unless these confounders are carefully controlled for and measured in these studies, there is a possibility to find association between PPIs and heart attacks without true causation," Kurlander says.

That said, known risks of PPIs can rarely include flatulence, diarrhea, headache, abdominal pain and nausea.

Hearing both sides

Another issue? Patients don't often hear of follow-up studies, Kurlander says.

For example, an October 2017 study in Gastroenterology debunks a 2016 study in JAMA Neurology that implied that long-term PPI use could contribute to cognitive decline. It's a report that received a lot of traction in mainstream media, yet the new study did not garner the same attention.

"Even if you believe that some of these adverse effects are real, the size of the effects tend to be small," Kurlander says. "Studies suggest that the excess risk of getting a bone fracture from a PPI is on the order of 0.3 percent per year per person. While it is something, people who have GERD or a peptic ulcer frequently find going without PPIs bothersome, and in patients who need PPIs to prevent ulcers, going without a PPI could cause a morbid or disabling bleeding event."

Before PPIs, the solution for ulcers was ugly, Kurlander says. It was typically a grueling surgery that involved cutting nerves or a part of the stomach.

PPIs have helped so many people, even colleagues in his office still take them regularly, says Kurlander.

Finding solutions

One benefit to the controversy surrounding PPIs: It encourages physicians to be more mindful of prescribing them, Kurlander says. Physicians examine why the patient is taking them, what evidence exists to support the decision, and the patient's risk tolerance to any potential long-term effects.

Good old-fashioned clean living has made a comeback as a result as well. Some of Kurlander's patients have elected to alter their lifestyle choices, including losing weight, avoiding trigger foods and eating earlier before bedtime, to cut down on the need for PPIs.

To schedule an appointment to discuss PPIs or digestive issues, call 888-229-7408.


More Articles About: Digestive Health Reflux or GERD Pharmacy Digestive (GI) Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Illustration of prescription bottle with a refill notice
Health Lab
In drive to deprescribe, heartburn drug study teaches key lessons
An effort to reduce use of PPI heartburn drugs in veterans because of overuse, cost and potential risks succeeded, but provides lessons about deprescribing efforts.
Researcher in white coat focuses gaze on microbes pictured in a twisting tube illustrating the gut
Health Lab
Fiber, genes and the gut microbiome: Study reveals possible triggers for inflammatory bowel disease
A new U-M study finds a complex interplay between diet, genes, and the gut microbiota that could explain why IBD develops.
Person's hand holding an aspirin tablet with a glass of water nearby
Health Lab
An aspirin a day? Some older adults who take it may be following outdated advice
Many people aged 50 to 80 who said they take aspirin multiple times a week may not need to do so and could be causing health risks, according to National Poll on Healthy Aging.
Older man with hand on forehead, dressed in camouflage clothing
Health Lab
Ketamine helped many severely depressed veterans, study shows
Intravenous (IV) ketamine helped relieve the depression symptoms of half of the veterans who received it at VA hospitals.
Image of woman with scientific objects, focusing on insulin resistance
Health Lab
Large genetic study reveals causes for insulin resistance, metabolic syndrome
Study uncovers genetic components of insulin resistance.
Illustration of physician with prescriptions, indicating online options
Health Lab
Few older adults use direct-to-consumer health services; those who do don’t tell their regular provider
Buying health care services directly online offers convenience but also risks if patients don’t tell their regular doctor or provider. Poll looks at older adults’ use and attitudes.